Search results
Combined flu and Covid jab produces ‘higher immune response’ than separate injections
The Telegraph via Yahoo News· 3 days agoA combined flu and Covid vaccine from Moderna has been found to provoke a higher immune response...
Why Moderna Stock Is a No-Brainer Buy Right Now
Motley Fool via Yahoo Finance· 4 days agoCMV is the top infectious cause of birth defects in the U.S. and currently has no approved vaccines. With Merck, Moderna is testing a combination of...
What to know about Moderna’s combined covid-flu vaccine on the horizon
Boston.com· 3 days agoModerna’s combined coronavirus-influenza shot reportedly produced a higher immune response in older...
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
Benzinga via AOL· 6 days agoOn Friday, Moderna Inc. (NASDAQ:MRNA) announced that it has submitted an FDA application for review...
Moderna to present combo COVID-flu vaccine to regulators after trial
Scripps News via AOL· 4 days agoModerna compared the immune response between those who were given mRNA-1083 versus those who were...
3 Reasons to Buy Moderna Stock
The Motley Fool via AOL· 6 days agoThere are currently no approved CMV vaccines. Then there's mRNA-1083, a potential combined COVID-influenza vaccine that Moderna also ...
Moderna (MRNA) Submits Updated COVID-19 Jab to FDA for Review
Zacks via Yahoo Finance· 4 days agoModerna (MRNA) completes regulatory filing of its Spikevax 2024-2025 formula, targeting the COVID-19...
A Combined Flu and COVID-19 Shot May Be Coming
Time via AOL· 3 days agoThe other half—the control group—received two separate shots: Moderna's latest COVID-19 vaccine, which targets the XBB.1.5 variant, and a flu shot...
Moderna Combination Shot Outperforms Standalone Flu, Covid-19 Jabs
Barrons.com· 4 days agoThe results could to upend the flu market if they withstand scrutiny from regulators. More than half...
Moderna Files FDA Application for the JN.1 Targeting COVID-19 Vaccine
The Kansas City Star· 7 days agoManufacturing is underway and doses of Moderna’s Spikevax 2024-2025 formula will be ready to ship as early as August, pending regulatory approval
